Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1,805 GBX | -0.26% | +2.53% | +24.50% |
02:36pm | US FDA declines to approve expanded use of Dynavax's hepatitis B vaccine | RE |
01:41pm | LBBW Raises GSK PT, Reiterates Buy Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+24.50% | 92.65B | |
+29.25% | 682B | |
+30.68% | 586B | |
-3.24% | 364B | |
+17.64% | 327B | |
+4.08% | 285B | |
+16.64% | 240B | |
+9.94% | 209B | |
-8.63% | 203B | |
+7.39% | 165B |
- Stock Market
- Equities
- GSK Stock
- News GSK plc
- Transcript : GSK plc Presents at Goldman Sachs 44th Annual Global Healthcare Conference, Jun-13-2023 09